Roger Sawhney

Insider Reports History

Entity
Individual
Location
C/O Omega Therapeutics, Inc., 20 Acorn Park D, Cambridge, MA
Signature
/s/ Paul Lytle, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Roger Sawhney:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Omega Therapeutics, Inc. Chief Financial Officer Option (Right to Buy) 60K Mar 9, 2022 Direct
ACTUATE THERAPEUTICS, INC. Director Non-Qualified Stock Options 30K Aug 12, 2024 Direct
ALIMERA SCIENCES INC Director Stock Option (Right to Buy) 2.25K Feb 25, 2023 Direct

Insider Reports Filed by Roger Sawhney

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ACTU ACTUATE THERAPEUTICS, INC. Aug 12, 2024 1 $0 4 Aug 14, 2024 Director
ACTU ACTUATE THERAPEUTICS, INC. Aug 12, 2024 0 $0 3 Aug 14, 2024 Director
ALIM ALIMERA SCIENCES INC Feb 25, 2023 1 $0 4 Mar 1, 2023 Director
ALIM ALIMERA SCIENCES INC Feb 25, 2023 0 $0 3 Mar 1, 2023 Director
OMGA Omega Therapeutics, Inc. Mar 9, 2022 1 $0 4 Mar 11, 2022 Chief Financial Officer
OMGA Omega Therapeutics, Inc. Aug 3, 2021 1 $50K 4 Aug 3, 2021 Chief Financial Officer
OMGA Omega Therapeutics, Inc. Jul 29, 2021 0 $0 3 Jul 29, 2021 Chief Financial Officer